Correction: GIP receptor agonism improves dyslipidemia and atherosclerosis independently of body weight loss in preclinical mouse model for cardio-metabolic disease

Cardiovasc Diabetol. 2024 Sep 12;23(1):341. doi: 10.1186/s12933-024-02407-8.
No abstract available

Publication types

  • Published Erratum